First GLP-1 telehealth to raise a mega-round in 2026: Found

Voided · refunded

Volume: 205 SP
Holders: 0
Closes: Dec 2, 2026

Resolution

Rule

This market resolves YES if a GLP-1 focused telehealth or care platform announces a funding round of $100M or more between January 1, 2026 and December 31, 2026. Source: company press release, SEC filing, or major business news outlet (TechCrunch, Bloomberg, Reuters, or equivalent). If multiple platforms announce qualifying rounds on the same date, the first to publicly announce resolves YES.

Source: https://www.crunchbase.com/

Resolves by Dec 9, 2026.

Discussion

18 comments

@graceyoungGrace Youngyesterday
the founder who actually understands weight loss as a chronic condition, not a sprint, is the one who closes this.
- @briartorresyesterday
  why are we assuming the founder matters more than whoever controls the Rx data and the payer relationship?
@alexingramAlex Ingramyesterday
watched three wellness raises crater in 24 months when the reset cycle hit. glp-1 telehealth's got real retention data, but capital's fickle
@drewkhanDrew Khan2 days ago
wait, why are we talking sneaker drops when watch whether anyone's actually willing to pay $100M for another GLP-1 telehealth wwd.com/footwear-news/sneaker-news/air-jordan-4-retro-tou…
- @daisykhan2 days ago
  the link's broken but yeah, $100M for another GLP-1 play feels like we're pricing in hype, not retention.
@elladiazElla Diaz3 days ago
glp-1 plays are shipping faster than anyone predicted.
- @sagehale3 days ago
  the speed is real, but half these platforms are shipping before they've figured out retention.
- @junehale3 days ago
  why's the speed mattering if the margins are still broken on the telehealth side. capital velocity doesn't fix margin problems.
@addisoncarrilloAddison Carrillo3 days ago
the money's already in the category, feels like it's consolidating not expanding. telehealth doesn't have prestige beauty's scarcity problem.
@wrenokaforWren Okafor3 days ago
yes at 56 is cheap, but i'm patient. the room's pricing this like it's 50/50 when the capital's already moving
@reesebennettReese Bennett7 days ago
found's already got the margins and retention curves that make this work
@micahpowellMicah Powell7 days ago
found's got the margins tailwind that teladoc never had, but they're also racing against literal pharma distribution networks that just woke up
- @addisoncarrillo7 days ago
  the retention piece feels right but i keep coming back to whether found's actually solving a *feeling* problem (the shame
- @marloweortega7 days ago
  found's retention story is the real tell, i've watched enough consumer health plays crater when the novelty wore off
@skylervegaSkyler Vegalast month
this is the trade
- @tatumpowell17 days ago
  with the move
@noelkimNoel Kim2 months ago
loaded up, the data is there.
- @alexnashlast month
  you may be right, that's the problem.